Ryoko Ihara

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Projected lecanemab wastage from vial discard: Simulation based on Japanese interim post-marketing surveillance summary statistics.

Projected lecanemab wastage from vial discard: Simulation based on Japanese interim post-marketing surveillance summary statistics.

Journal: Journal of Alzheimer's disease : JAD

Published: July 21, 2026

SWI and T2*-GRE Microhemorrhage Counts in Anti-Amyloid Therapy Eligibility: A Real-World-Calibrated Simulation Study.

SWI and T2*-GRE Microhemorrhage Counts in Anti-Amyloid Therapy Eligibility: A Real-World-Calibrated Simulation Study.

Journal: medRxiv : the preprint server for health sciences

Published: July 03, 2026

Potential and biases of large language model simulation for public surveys on Alzheimer's disease therapies.

Potential and biases of large language model simulation for public surveys on Alzheimer's disease therapies.

Journal: Journal of Alzheimer's disease : JAD

Published: June 27, 2026

MMSE-CDR-SB residual as an exploratory indicator of deviation from an Alzheimer's disease-typical cognitive-functional pattern.

MMSE-CDR-SB residual as an exploratory indicator of deviation from an Alzheimer's disease-typical cognitive-functional pattern.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: May 23, 2026

Early-onset Alzheimer's disease with PSEN1 G206D mutation presenting with amnesia at an onset age of 29 years old

Early-onset Alzheimer's disease with PSEN1 G206D mutation presenting with amnesia at an onset age of 29 years old

Journal: Rinsho shinkeigaku = Clinical neurology

Published: April 12, 2026

Clinical and MRI features associated with amyloid positivity in secondary screening for anti-amyloid-β therapy.

Clinical and MRI features associated with amyloid positivity in secondary screening for anti-amyloid-β therapy.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: February 27, 2026

Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's disease treated with Lecanemab: A real-world study.

Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's disease treated with Lecanemab: A real-world study.

Journal: The journal of prevention of Alzheimer's disease

Published: January 20, 2026

ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab.

ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab.

Journal: The journal of prevention of Alzheimer's disease

Published: January 11, 2026

Utility of APOE testing for reducing ARIA under probabilistic stopping rates to treat with anti-amyloid therapy for ε4-homozygote patients: A simulation study.

Utility of APOE testing for reducing ARIA under probabilistic stopping rates to treat with anti-amyloid therapy for ε4-homozygote patients: A simulation study.

Journal: JAR life

Published: December 01, 2025

Prediction of one-year cognitive decline via self-perceived memory in older adults during the COVID-19 pandemic.

Prediction of one-year cognitive decline via self-perceived memory in older adults during the COVID-19 pandemic.

Journal: JAR life

Published: November 25, 2025

Therapeutic Time Window of Disease-Modifying Therapy for Early Alzheimer's Disease in Japanese Individuals: Analysis Based on J-ADNI Study.

Therapeutic Time Window of Disease-Modifying Therapy for Early Alzheimer's Disease in Japanese Individuals: Analysis Based on J-ADNI Study.

Journal: Geriatrics & gerontology international

Published: November 18, 2025

Property difference in Mini-Mental State Examination Serial Sevens and World Backwards: Analysis using item response theory.

Property difference in Mini-Mental State Examination Serial Sevens and World Backwards: Analysis using item response theory.

Journal: Journal of Alzheimer's disease : JAD

Published: October 09, 2025

Showing 1-12 of 67

Last Updated: 09/26/2026